FDA Needs 5 To 10 Years Of Rebuilding, Chief Scientist Goodman Says
This article was originally published in The Pink Sheet Daily
Executive Summary
At Hill briefing, Rep. DeLauro praises the Sentinel initiative and Commissioner Hamburg but expresses dismay about the "knowledge shortfall" at the agency.
You may also be interested in...
FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs
Jesse Goodman will become director of Georgetown University’s new Center on Medical Product Access, Safety and Stewardship while Stephen Ostroff steps up as FDA’s Acting Chief Scientist.
FDA’s Acting Chief Scientist Offers Vaccine Continuity As Goodman Departs
Jesse Goodman will become director of Georgetown University’s new Center on Medical Product Access, Safety and Stewardship while Stephen Ostroff steps up as FDA’s Acting Chief Scientist.
Who Will Lead FDA In The Future? Succession Plan Is Not Enough, GAO Says
In its latest report card on FDA, the Government Accountability Office examines the agency's management of such challenges as recruiting and retaining its workforce and communicating with the public